All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic LeukemiaMartin S. Tallman, Peter H. Wiernik, Clara D. Bloomfield et al.|New England Journal of Medicine|1997Cited by 1.1k
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)Anthony H. Goldstone, Jacob M. Rowe, Susan Richards et al.|Blood|2007Cited by 782
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trialAnthony V. Moorman, Gordon W. Dewald, Christine J. Harrison et al.|Blood|2006Cited by 746
Cytosine arabinoside with daunorubicin or adriamycin for therapy of acute myelocytic leukemia: a CALGB studyJerome W. Yates, JF Holland, O Glidewell et al.|Blood|1982Cited by 527